“Trastuzumab-Induced Cardiotoxicity in Patients With HER-2 Positive Breast Cancer ”. Research, Society and Development, vol. 11, no. 15, Nov. 2022, p. e114111536597, https://doi.org/10.33448/rsd-v11i15.36597.